Emergent BioSolutions Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (36)

Latest Posts

About This Stock More About This Stock
Quick Reminder: Insider Trading Does Not Maximize Shareholder Value
Article By: Dean Baker
Sunday, July 26, 2020 7:39 PM EST
Insider trading effectively means top executives are stealing from the companies they run. Excitement over potential covid vaccines may be causing irregularities at at least 9 biopharmas, according to the NYT.
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EST
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Emergent BioSolutions Get Approval For New Construction Site In Germany
Article By: KKD Healthcare Analytics
Monday, January 30, 2017 12:50 PM EST
Emergent BioSolutions announced receiving approval from German Federal Ministry of Health for the construction of Building 55. The building will be used for manufacturing BioThrax.
In this article: EBS
GlaxoSmithKline Q1 Earnings Lag, Revenues Up Y/Y
Article By: Zacks Investment Research
Thursday, April 28, 2016 8:30 PM EST
GlaxoSmithKline PLC reported first-quarter 2016 core earnings of 57 cents per American Depositary Share (ADS), missing the Zacks Consensus Estimate of 60 cents. Nevertheless, the company’s shares inched up 1.8% following the news.
In this article: EBS, GSK, NVS, ANIK
Top 5 Stocks With Increasing Cash Flows
Article By: Zacks Investment Research
Tuesday, April 26, 2016 4:39 AM EST
While in the heart of the first-quarter earnings season, investors might find it easy to look for profits and surprises to scoop up big gains.
In this article: EBS, FOR, JBT, ANIK, NSAT

Latest Tweets for $EBS

No tweets yet!